Filing Details
- Accession Number:
- 0001209191-15-030195
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2015-03-30 17:13:10
- Reporting Period:
- 2015-03-19
- Filing Date:
- 2015-03-30
- Accepted Time:
- 2015-03-30 17:13:10
- Original Submission Date:
- 2015-03-23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1037760 | Cepheid | CPHD | Laboratory Analytical Instruments (3826) | 770441625 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1240656 | H Joseph Smith | C/O Cepheid 904 Caribbean Drive Sunnyvale CA 94089 | Evp, Bus Dev And Gc | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-03-19 | 10,000 | $9.08 | 24,323 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-03-19 | 2,486 | $19.85 | 26,809 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-03-19 | 12,486 | $60.00 | 14,323 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2015-03-19 | 10,000 | $0.00 | 10,000 | $9.08 |
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2015-03-19 | 2,486 | $0.00 | 2,486 | $19.85 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 34,352 | 2006-01-01 | 2015-04-27 | No | 4 | M | Direct |
| 57,514 | 2009-04-24 | 2015-04-24 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- Share total exercised and sold as corrected by broker after original report on Form 4 filed 3/23/15.
- 1/48th of the shares subject to the grant vest and become exercisable monthly from the grant date, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
- 25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
Billionaire Hedge Funds
